Walleye Capital LLC Novavax Inc Call Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $521,577 - $833,257	-48,700 Reduced 70.07%	20,800 $262,000
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $254,017 - $1.37 Million	65,300 Added 1554.76%	69,500 $879,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $15,792 - $25,284	4,200 New	4,200 $20,000
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $94,047 - $134,232	-14,100 Reduced 59.75%	9,500 $70,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $12,672 - $27,456	2,200 Added 10.28%	23,600 $163,000
Q4 2022 Feb 14, 2023	SELL	$8.86 - $25.04 $44,300 - $125,200	-5,000 Reduced 18.94%	21,400 $219,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $480,480 - $2.01 Million	26,400 New	26,400 $480,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.